Home > Financial Ratios > LYKA LABS

LYKA LABS
Core EBITDA Growth

    Back to All Ratios
LYKA LABS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -15.17-80.40385.973,765.48-402.66

What is the latest Core EBITDA Growth ratio of LYKA LABS ?

The latest Core EBITDA Growth ratio of LYKA LABS is -15.17 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-15.17
Mar2023-80.40
Mar2022385.97
Mar20213,765.48
Mar2020-402.66

How is Core EBITDA Growth of LYKA LABS Trending?

Years Core EBITDA Growth % Change
Mar2024 -15.17
Negative
Mar2023 -80.4
Negative
Mar2022 385.97
-89.75
Mar2021 3765.48
Positive
Mar2020 -402.66 -

Other Financial Ratios of LYKA LABS


Compare Core EBITDA Growth ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹420.2 Cr 0.4% 6% 9.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,824.0 Cr 0.5% -0.5% 14.6% Stock Analytics
DIVIS LABORATORIES ₹178,355.0 Cr 1.3% 10.7% 49.3% Stock Analytics
CIPLA ₹122,929.0 Cr 2.2% 0.2% 2.3% Stock Analytics
DR REDDYS LABORATORIES ₹112,701.0 Cr 4.7% 11.9% 14.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,502.0 Cr 2% -0.8% 15.7% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

0.4%

6%

9.7%

SENSEX

1.9%

0.1%

10.9%


You may also like the below Video Courses